Stay updated on DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial
Sign up to get notified when there's something new on the DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial page.

Latest updates to the DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedThe revision tag on the page was updated from v3.5.2 to v3.5.3. This indicates a minor release update to the page, with no substantive content changes evident.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No study content or essential functionality was altered.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page now displays Revision: v3.4.3 and removes the previous Revision: v3.4.2.SummaryDifference0.0%

- Check88 days agoChange DetectedAdded Revision: v3.4.2. Removed the government funding lapse notice and Revision: v3.4.1.SummaryDifference0.3%

- Check95 days agoChange DetectedAdded a government funding/status notice and updated the page revision to v3.4.1, while removing the previous v3.4.0 tag. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial page.